Molecular biological analysis and treatment for diabetic retinopathy
Molecular biological analysis and treatment for diabetic retinopathy
批准号:
16591774
负责人:
OGATA Nahoko
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
糖尿病视网膜病变是成人失明的主要原因。我们研究了2型糖尿病模型--自发性糖尿病大鼠视网膜的变化,并探讨了糖尿病视网膜病变的分子控制机制。在一些SDT大鼠的眼睛中发现了类似于人类增殖性糖尿病视网膜病变(PDR)的增殖组织。然而,SDT大鼠视网膜新生血管发生率低,视网膜非灌注区发育不良。血管生成主要刺激因子血管内皮生长因子(VEGF)和血管生成抑制因子色素上皮衍生因子(PEDF)在SDT大鼠视网膜中的表达均增加。PEDF可抑制血管内皮细胞生长因子诱导的白血球沉积。因此,SDT大鼠视网膜中高水平的PEDF可能是导致新生血管形成的低发生率以及缺乏与典型的人类糖尿病视网膜病变不匹配的非灌注区的原因之一。在人PDR组织中,VEGF和PEDF均有较强的表达,但分布不同。血小板衍生微粒(PDMPs)刺激凝血级联反应,增加白细胞与内皮细胞的黏附,单核细胞衍生微粒(MDMPs)从激活的单核细胞中释放出来,增强促凝血活性。这些活动是糖尿病视网膜病变发展过程中的关键事件。PDMPs和MDMPs相互关联,并与活化的血小板(CD62p和CD63)和黏附分子(P-选择素和ICAM-1)相关。PDMPs和MDMPs随着糖尿病视网膜病变的进展而增加。因此,MDMPs和PDMPs水平的升高可能会加速糖尿病视网膜病变的进展。
英文摘要
Diabetic retinopathy is a major cause of blindness in adults. We investigate the retinal changes in SDT (Spontaneously Diabetic Torii) rats, a model of type 2 diabetic mellitus, and the molecular mechanisms controlling the diabetic retinopathy. Propliferative tissues that are similar to human proliferative diabetic retinopathy (PDR) are found in eyes of some of the SDT rats. However, SDT rats have a low incidence of retinal neovascularization and poor development of retinal non-perfused areas. Expression of vascular endothelial growth factor (VEGF), a major angiogenic stimulator, and pigment epithelium-derived factor (PEDF), an angiogenic inhibitor, were both increased in the retina of SDT rats. PEDF inhibited the VEGF-induced leukostasis. Thus, the high levels of PEDF in the retina of SDT rats may contribute to the low incidence of neovascular formation and absence of non-perfused areas that did not match the typical diabetic retinopathy in humans. In human PDR tissues, VEGF and PEDF were both strongly expressed, but the distribution was different.Platelet-derived microparticles (PDMPs) stimulate the coagulation cascade and increase leukocyte and endothelial cell adhesions, and monocytes-derived microparticles (MDMPs) are released from activated monocytes and enhance the procoagulant activity. These activities are key events in the development of diabetic retinopathy. PDMPs and MDMPs are correlated with each other and also correlated with activated platelet (CD62P and CD63) and adhesion molecules (P-selectin and ICAM-1). PDMPs and MDMPs are increased according to the progression of diabetic retinopathy. Therefore, increased levels of MDMPs and PDMPs may accelerate the progression of diabetic retinopathy.
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/01.cir.0000130643.41587.db
发表时间:
2004-06-22
期刊:
CIRCULATION
影响因子:
37.8
作者:
[Hashiya, N, Jo, N, Morishita, R]
通讯作者:
Morishita, R
Deceased levels of pigment epithelium-derived factor in eyes with neuroretinal dystrophic diseases.
患有神经视网膜营养不良性疾病的眼睛中色素上皮衍生因子的水平降低。
DOI:
--
发表时间:
2004
期刊:
American Journal of Ophthalmology 137
影响因子:
--
作者:
[Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M]
通讯作者:
Matsumura M
Pigment epithelium-derived factor in eyes an aging
眼睛色素上皮衍生因子与衰老
DOI:
--
发表时间:
2004
期刊:
Japanese Review of Clinical Ophthalmology 98
影响因子:
--
作者:
[Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M]
通讯作者:
Matsumura M
Trans-Tenon's retrobulbare injection of triamcinolone acetonide for diffuse diabetic macular edema
Trans-Tenon球后注射曲安奈德治疗弥漫性糖尿病黄斑水肿
DOI:
--
发表时间:
2005
期刊:
Japanese Joumal of Ophthalmology 49
影响因子:
--
作者:
[Wada M, Ogata N, Minamino S, Koriyama M, Higuchi A, Matsumura M]
通讯作者:
Matsumura M
Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabtic macular edema
Trans-Tenon球后注射曲安奈德治疗弥漫性糖尿病性黄斑水肿
DOI:
--
发表时间:
2006
期刊:
Japanese Journal of Ophthalmology 49
影响因子:
--
作者:
[Wada M, Ogata N, Minamino K, Koriyama M, Higuchi A, Matsumura M]
通讯作者:
Matsumura M
共 17 条
Molecular biological study and treatment for diabetic retinopathy
-
批准号:18591943
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:OGATA Nahoko
-
依托单位:
Molecular Mechanism and i Therapy for Choroidal Neovascularization
-
批准号:14571694
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:OGATA Nahoko
-
依托单位:
Control of Ocular Proliferation and Neuroprotection by Gene Therapy and Analysis of These Molecular Mechanisms.
-
批准号:12671730
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:OGATA Nahoko
-
依托单位:
Gene Therapy and Transplantation of Retinal Pigment Epithelium for Ocular Proliferative Deseases and Retinal Degeneration
-
批准号:10671662
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:OGATA Nahoko
-
依托单位:
Molecular biological study to evaluate the function of growth factors and treament in ocular angiogenesis
-
批准号:08672043
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:OGATA Nahoko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: